Oxford Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for OXFORD PHARMS, and what generic and branded alternatives to OXFORD PHARMS drugs are available?
OXFORD PHARMS has thirty-three approved drugs.
Summary for Oxford Pharms
| US Patents: | 0 |
| Tradenames: | 30 |
| Ingredients: | 30 |
| NDAs: | 33 |
Drugs and US Patents for Oxford Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oxford Pharms | NABUMETONE | nabumetone | TABLET;ORAL | 079093-001 | Feb 27, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Oxford Pharms | ALPRAZOLAM | alprazolam | TABLET;ORAL | 078491-001 | Sep 25, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Oxford Pharms | GLIPIZIDE | glipizide | TABLET;ORAL | 074378-002 | Nov 28, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Oxford Pharms | TIZANIDINE HYDROCHLORIDE | tizanidine hydrochloride | TABLET;ORAL | 076281-001 | Oct 20, 2003 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Oxford Pharms | GLIPIZIDE | glipizide | TABLET;ORAL | 074378-001 | Nov 28, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Oxford Pharms | SERTRALINE HYDROCHLORIDE | sertraline hydrochloride | TABLET;ORAL | 078175-001 | Jul 21, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
